UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ 22,609	$ (23,278)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of contingent consideration	(384)	(106)
Change in fair value of Contract Consideration Convertible Notes Payable	(29,969)	(9,016)
Amortization of convertible note issuance cost	83	663
Paid-in-kind interest expense	2,284	3,861
Amortization of contract assets	3,665	1,986
Depreciation	530	554
Amortization of asset-based loan origination costs	36	0
Provision for credit losses, net of recoveries	97	147
Provision for excess and obsolete inventory	626	1,702
Gain on sale of property and equipment	(38)	(1,916)
Gain on lease termination	0	(584)
Lease expense	2,316	168
Stock compensation expense	(565)	2,262
Deferred income tax benefit	50	1
Paycheck protection plan loan forgiveness	(4,522)	0
Changes in current assets and liabilities:
Accounts receivable	3,472	(5,748)
Accounts receivable, related party	(2,082)	(24,616)
Inventories	(776)	(11,373)
Income taxes receivable	0	3
Other assets	(863)	(537)
Contract assets	0	(3,600)
Accounts payable	60	22,036
Accrued liabilities	(3,179)	493
Operating lease liabilities	(2,636)	(404)
Income taxes payable	(54)	100
Interest payable	(8)	36
Net cash used in operating activities	(9,248)	(47,166)
Cash flows from investing activities:
Capital expenditures	(593)	(175)
Proceeds from sale of assets	68	4,215
Net cash (used in) provided by investing activities	(525)	4,040
Cash flows from financing activities:
Payment for forfeited stock options	(617)	0
Payments on long term debt	(104)	0
Proceeds from asset-based loan	27,750	0
Payments on asset-based loan	(24,380)	0
Payment of asset-based loan origination costs	(502)	0
Proceeds from issuance of convertible notes	0	21,150
Payment of issuance costs of convertible notes	0	(1,084)
Proceeds from issuance of warrants	0	19,500
Payment of issuance costs of stock warrants	0	(1,170)
Payments to tax authorities for shares withheld from employees	(246)	(191)
Proceeds from issuance of stock	48	24
Payments for finance leases	(24)	(30)
Net cash provided by financing activities	1,925	38,199
Effect of changes in exchange rates on cash and cash equivalents	13	211
Net change in cash and cash equivalents and restricted cash	(7,835)	(4,716)
Cash and cash equivalents at the beginning of period	12,290	11,534
Restricted cash at the beginning of period	100	1,790
Cash and cash equivalents and restricted cash at beginning of period	12,390	13,324
Cash and cash equivalents at end of period	4,453	8,508
Restricted cash at the end of period	102	100
Cash and cash equivalents and restricted cash at end of period	$ 4,555	$ 8,608